Last Updated: Thursday, May 5th 2022 2:01:16 PM EDT
David Haegert, M.D.
Research Interests
* Multiple sclerosis and changes in T-cells that predict rates of disease progression
* Developing biomarkers that distinguish between MS patients having rapid vs. slow disease progression, in particular progression to secondary progressive MS which is the main determinant of long-term prognosis in MS patients
* Developing biomarkers that distinguish between MS patients having rapid vs. slow disease progression, in particular progression to secondary progressive MS which is the main determinant of long-term prognosis in MS patients
Consultations: No
Focus Groups: No
